Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Fairmount Funds Management LLC reported a 4.90% stake in Dianthus Therapeutics, Inc. (Schedule 13D/A)

Event Nov 21, 2025 · Filed Nov 25, 2025

Fairmount Funds Management LLC reported a 4.90% stake in Dianthus Therapeutics, Inc., 2,139,635 shares, with active intent on Nov 21, 2025. Filed Nov 25, 2025 (Schedule 13D/A).

Stake
4.90%
Shares
2,139,635
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC4.90%2,139,635
Fairmount Healthcare Fund II L.P.4.90%2,139,635
Peter Evan Harwin4.90%2,139,635
Tomas Kiselak4.90%2,139,635

Source

View original at SEC

Related